“An estimated 54 billion molecules were screened by 130 teams representing more than 500 scientists from the world’s top institutions. The VirtualFlow team, consisting of scientists from the US (Harvard, DFCI, Google and University of California, Berkeley), Austria (Innophore), Germany (Max Planck Institute and Technical University of Berlin) and Ukraine (Enamine and Chemspace), is now in the finalist phase, competing with the few remaining drug discovery teams to win the prestigious Covid19 GrandChallenge, organized by the Joint European Disruptive Initiative (JEDI) , the “European DARPA”. It is to be noted that only teams that have submitted drug proposals with real potential to treat Covid-19 have been selected for the finalist round.”
By February 2021, 878 of the most promising molecules have now been synthesised, compounds that were not available in any molecular library in the world. This is an immense and unprecedented undertaking in human history.
Catalophore™ DrugSolver Platform
Reliable drug (off-)target identification
Virtual drug side-effect screening
Drug design, discovery and repositioning
Large-scale drug repurposing
Protein and pathway optimization